The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program

被引:7
|
作者
Roman, M. [1 ,2 ]
Skaane, P. [3 ]
Hofvind, S. [1 ,4 ]
机构
[1] Canc Registry Norway, N-0403 Oslo, Norway
[2] Oslo Univ Hosp, Dept Women & Childrens Hlth, Oslo, Norway
[3] Univ Oslo, Dept Radiol, Oslo Univ Hosp Ullevaal, Oslo, Norway
[4] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Oslo, Norway
关键词
Breast neoplasms; Mass screening; Mammography; False positive reactions; Predictive value of tests; CORE NEEDLE-BIOPSY; DIGITAL MAMMOGRAPHY; FINE-NEEDLE; CONSEQUENCES; PERFORMANCE; ACCURACY; LESIONS; RECALL; IMPACT;
D O I
10.1016/j.ejrad.2014.05.038
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Recall for assessment in mammographic screening entails an inevitable number of false-positive screening results. This study aimed to investigate the variation in the cumulative risk of a false positive screening result and the positive predictive value across the screening centres in the Norwegian Breast Cancer Screening Program. Methods: We studied 618,636 women aged 50-69 years who underwent 2,090,575 screening exams (1996-2010. Recall rate, positive predictive value, rate of screen-detected cancer, and the cumulative risk of a false positive screening result, without and with invasive procedures across the screening centres were calculated. Generalized linear models were used to estimate the probability of a false positive screening result and to compute the cumulative false-positive risk for up to ten biennial screening examinations. Results: The cumulative risk of a false-positive screening exam varied from 10.7% (95% CI: 9.4-12.0%) to 41.5% (95% CI: 34.1-48.9%) across screening centres, with a highest to lowest ratio of 3.9 (95% CI:3.7-4.0). The highest to lowest ratio for the cumulative risk of undergoing an invasive procedure with a benign outcome was 4.3 (95% CI: 4.0-4.6). The positive predictive value of recall varied between 12.0% (95% CI: 11.0-12.9%) and 19.9% (95% CI: 18.3-21.5%), with a highest to lowest ratio of 1.7 (95% CI: 1.5-1.9). Conclusions: A substantial variation in the performance measures across the screening centres in the Norwegian Breast Cancer Screening Program was identified, despite of similar administration, procedures, and quality assurance requirements. Differences in the readers' performance is probably of influence for the variability. This results underscore the importance of continuous surveillance of the screening centres and the radiologists in order to sustain and improve the performance and effectiveness of screening programs. (C)2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1639 / 1644
页数:6
相关论文
共 50 条
  • [1] The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program
    Rosenberg, R. D.
    Linver, M. N.
    Breast Diseases, 2015, 26 (01): : 43 - 45
  • [2] The Cumulative Risk of False-Positive Results in the Norwegian Breast Cancer Screening Program: Updated Results
    Roman, Marta
    Hubbard, Rebecca A.
    Sebuodegard, Sofie
    Miglioretti, Diana L.
    Castells, Xavier
    Hofvind, Solveig
    CANCER, 2013, 119 (22) : 3952 - 3958
  • [3] The cumulative risk of a false-positive recall in the Norwegian breast cancer screening program
    Hofvind, S
    Thoresen, S
    Tretli, S
    CANCER, 2004, 101 (07) : 1501 - 1507
  • [4] False-positive results in breast cancer screening
    Evans, MF
    CANADIAN FAMILY PHYSICIAN, 1999, 45 : 73 - 74
  • [5] Risk of breast cancer after false-positive results in mammographic screening
    Roman, Marta
    Castells, Xavier
    Hofvind, Solveig
    von Euler-Chelpin, My
    CANCER MEDICINE, 2016, 5 (06): : 1298 - 1306
  • [6] Estimating the cumulative risk of a false-positive test in a repeated screening program
    Xu, JL
    Fagerstrom, RM
    Prorok, PC
    Kramer, BS
    BIOMETRICS, 2004, 60 (03) : 651 - 660
  • [7] Estimating the cumulative risk of a false-positive test in a repeated screening program
    Xu, Jian-Lun
    Fagerstrom, Richard M.
    Prorok, Philip C.
    Kramer, Barnett S.
    Biometrics, 3 (651-660):
  • [8] Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme
    Molins, E.
    Comas, M.
    Roman, R.
    Rodriguez-Blanco, T.
    Sala, M.
    Macia, F.
    Murta-Nascimento, C.
    Castells, X.
    PUBLIC HEALTH, 2009, 123 (09) : 635 - 637
  • [9] Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
    Croswell, Jennifer Miller
    Kramer, Barnett S.
    Kreimer, Aimee R.
    Prorok, Phil C.
    Xu, Jian-Lun
    Baker, Stuart G.
    Fagerstrom, Richard
    Riley, Thomas L.
    Clapp, Jonathan D.
    Berg, Christine D.
    Gohagan, John K.
    Andriole, Gerald L.
    Chia, David
    Church, Timothy R.
    Crawford, E. David
    Fouad, Mona N.
    Gelmann, Edward P.
    Lamerato, Lois
    Reding, Douglas J.
    Schoen, Robert E.
    ANNALS OF FAMILY MEDICINE, 2009, 7 (03) : 212 - 222
  • [10] Modelling the cumulative risk of a false-positive screening test
    Baker, Stuart G.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2011, 20 (03) : 291 - 293